Drawing for ACRO ASSOCIATION OF CLINICAL RESEARCH ORGANIZATIONS

USPTO serial 76428840

ACRO ASSOCIATION OF CLINICAL RESEARCH ORGANIZATIONS

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
PINO, BRIAN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ACRO ASSOCIATION OF CLINICAL RESEARCH ORGANIZATIONS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

A. Statton Hammock, Jr., Esquire

A STATTON HAMMOCK, JR ESQ O'BRIEN, BUTLER, MCCONIHE & SCHAEFER888 SEVENTEENTH ST N W STE 1000WASHINGTON, DC 20006UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
016PRINTED PUBLICATIONS, NAMELY, BOOKS, NEWSLETTERS, MAGAZINES, PAMPHLETS, AND BROCHURES DIRECTED TO CLINICAL RESEARCHERS and CLINICAL RESEARCH ORGANIZATIONSACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 15, 2003ABN1ABANDONMENT - EXPRESS MAILED—
Apr 10, 2003CFITCASE FILE IN TICRS—
Mar 25, 2003MAILPAPER RECEIVED—
Feb 4, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 29, 2003DOCKASSIGNED TO EXAMINER—
Jan 8, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance